Novonesis biosolutions for human health – advancing well-being through science-driven innovation
Home
IFF continues divestment...

IFF continues divestment strategy with sale of Flavor Specialty Ingredients Business to Exponent in US$220M deal

17 Feb 2023
Revervia
trans